Acute Pulmonary Embolism Clinical Pathway — Emergency Department, ICU and Inpatient
Acute Pulmonary Embolism Clinical Pathway — Emergency Department, ICU and Inpatient
Goals
- Standardize evaluation and initial management for patients with diagnosed pulmonary embolism on CTA or suspected PE with acute decompensation
- Standardize risk stratification for patients with PE
- Facilitate multi-disciplinary management for intermediate and high-risk patients via PE Response Team
- Standardize outpatient follow up for patients with PE
Metrics
- Proportion of patients diagnosed with PE who have full laboratory workup ordered prior to or within 2 hours of CTA
- CBC, CMP, PT, PTT, fibrinogen, D-dimer, troponin, BNP
- Proportion of patients with diagnosed PE who have an echo within appropriate time period per pathway
- Low risk: < 24 hours after CTA result
- Intermediate/high risk: < 6 hours after CTA result
- Proportion with anticoagulation started < 2 hours after CTA result
- Enoxaparin or heparin (bolus or infusion if no bolus given) given to patient (i.e., not just ordered) < 2 hours after CTA result
- Time to therapeutic anticoagulation (for each drug individually)
- If unfractionated heparin: time from start of bolus or infusion (if no bolus given) to first therapeutic PTT/heparin anti-Xa
- If enoxaparin: time from first dose to first therapeutic enoxaparin anti-Xa
- CTA quality (Quality will be denoted in the radiology reports going forward as: poor, adequate, fair, or excellent)
- Percent of PE that is high or intermediate risk
- In-hospital mortality
- ICU admission (includes any PICU, CICU, NICU)
- Length of stay (hospitalization LOS, ED LOS, ICU LOS)
- Readmission within 30 days